Cardlytics Inc [NASDAQ: CDLX] gained 4.55% on the last trading session, reaching $2.07 price per share at the time.
If compared to the average trading volume of 960.05K shares, CDLX reached a trading volume of 6606063 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Cardlytics Inc [CDLX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CDLX shares is $3.30 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CDLX stock is a recommendation set at 3.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for Cardlytics Inc shares, keeping their opinion on the stock as In-line, with their previous recommendation back on October 11, 2024. The new note on the price target was released on August 16, 2024, representing the official price target for Cardlytics Inc stock. Previously, the target price had yet another drop from $4 to $3.50, while BofA Securities kept a Underperform rating on CDLX stock.
The Average True Range (ATR) for Cardlytics Inc is set at 0.29, with the Price to Sales ratio for CDLX stock in the period of the last 12 months amounting to 0.36. The Price to Book ratio for the last quarter was 1.50, with the Price to Cash per share for the same quarter was set at 1.32.
Trading performance analysis for CDLX stock
Cardlytics Inc [CDLX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.59. With this latest performance, CDLX shares dropped by -38.58% in over the last four-week period, additionally sinking by -35.51% over the last 6 months – not to mention a drop of -75.62% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CDLX stock in for the last two-week period is set at 33.95, with the RSI for the last a single of trading hit 33.88, and the three-weeks RSI is set at 35.51 for Cardlytics Inc [CDLX]. The present Moving Average for the last 50 days of trading for this stock 3.0500, while it was recorded at 1.9800 for the last single week of trading, and 4.7700 for the last 200 days.
Cardlytics Inc [CDLX]: A deeper dive into fundamental analysis
Cardlytics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.18 and a Current Ratio set at 1.18.
An analysis of Institutional ownership at Cardlytics Inc [CDLX]
There are presently around $59.11%, or 62.38%% of CDLX stock, in the hands of institutional investors. The top three institutional holders of CDLX stocks are: CAS INVESTMENT PARTNERS, LLC with ownership of 6.46 million shares, which is approximately 13.1785%. BLACKROCK INC., holding 3.15 million shares of the stock with an approximate value of $$25.88 million in CDLX stocks shares; and BLACKROCK INC., currently with $$19.81 million in CDLX stock with ownership which is approximately 5.5784%.
